Infection of the Upper Respiratory Tract with Seasonal Influenza A(H3N2) Virus Induces Protective Immunity in Ferrets against Infection with A(H1N1)pdm09 Virus after Intranasal, but Not Intratracheal, Inoculation

ABSTRACT The clinical symptoms caused by infection with influenza A virus vary widely and depend on the strain causing the infection, the dose and route of inoculation, and the presence of preexisting immunity. In most cases, seasonal influenza A viruses cause relatively mild upper respiratory tract disease, while sometimes patients develop an acute severe pneumonia. Heterosubtypic immunity induced by previous infections with influenza A viruses may dampen the development of clinical symptoms caused by infection with influenza A viruses of another subtype, as is the case during influenza pandemics. Here we show that ferrets acquire protective immunity after infection of the upper respiratory tract with a seasonal influenza A(H3N2) virus against subsequent infection with influenza A(H1N1)pdm09 virus inoculated by the intranasal route. However, protective heterosubtypic immunity was afforded locally, since the prior infection with the A(H3N2) virus did not provide protection against the development of pneumonia induced after intratracheal inoculation with the A(H1N1)pdm09 virus. Interestingly, some of these animals developed more severe disease than that observed in naïve control animals. These findings are of interest in light of the development of so-called universal influenza vaccines that aim at the induction of cross-reactive T cell responses.

[1]  R. Webster,et al.  Evolution and ecology of influenza A viruses. , 1992, Current topics in microbiology and immunology.

[2]  John Steel,et al.  Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.

[3]  P. Horby,et al.  Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.

[4]  Albert D. M. E. Osterhaus,et al.  Comparison of Temporal and Spatial Dynamics of Seasonal H3N2, Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Virus Infections in Ferrets , 2012, PloS one.

[5]  R. Hai,et al.  Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice , 2012, Journal of Virology.

[6]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[7]  Tao Dong,et al.  Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  G. Shanks,et al.  Pathogenic Responses among Young Adults during the 1918 Influenza Pandemic , 2012, Emerging infectious diseases.

[9]  L. Boon,et al.  Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity , 2012, PloS one.

[10]  G. Rimmelzwaan,et al.  Immune responses to influenza virus infection. , 2011, Virus research.

[11]  A. Osterhaus,et al.  Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines , 2011, Journal of biomedicine & biotechnology.

[12]  T. Kuiken,et al.  Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. , 2011, The Journal of general virology.

[13]  J. Skehel,et al.  A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins , 2011, Science.

[14]  Surender Khurana,et al.  Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin , 2011, Proceedings of the National Academy of Sciences.

[15]  T. Kuiken,et al.  Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. , 2011, The American journal of pathology.

[16]  R. Webster,et al.  Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. , 2011, Vaccine.

[17]  T. Kuiken,et al.  Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets , 2011, Journal of Virology.

[18]  A. Hill,et al.  Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1 , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  B. Cowling,et al.  Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical Infectious Diseases.

[20]  D. Ekiert,et al.  Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes , 2010, Proceedings of the National Academy of Sciences.

[21]  Deborah Middleton,et al.  Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. , 2010, The Journal of infectious diseases.

[22]  Michael G. Katze,et al.  Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice , 2010, PLoS pathogens.

[23]  H. Yen,et al.  Host response to influenza virus: protection versus immunopathology. , 2010, Current opinion in immunology.

[24]  T. Uyeki,et al.  Immunopathology and Infectious Diseases 2009 Pandemic Influenza A ( H 1 N 1 ) Pathology and Pathogenesis of 100 Fatal Cases in the United States , 2010 .

[25]  T. Kuiken,et al.  A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets , 2010, Journal of Virology.

[26]  Ron A M Fouchier,et al.  Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus , 2010, The Journal of infectious diseases.

[27]  John Steel,et al.  Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain , 2010, mBio.

[28]  Víctor Hugo Borja-Aburto,et al.  Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis , 2009, The Lancet.

[29]  S. Bezerra,et al.  Lung pathology in fatal novel human influenza A (H1N1) infection. , 2010, American journal of respiratory and critical care medicine.

[30]  J. Silva-Pereyra,et al.  Pathological changes associated with the 2009 H1N1 virus. , 2009, The New England journal of medicine.

[31]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[32]  R. Perez-Padilla,et al.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. , 2009, The New England journal of medicine.

[33]  Mark R. Soboleski,et al.  Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. , 2009, Vaccine.

[34]  A. García-Sastre,et al.  Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment , 2009, Journal of Virology.

[35]  Emma S McBryde,et al.  Influenza: accounting for prior immunity. , 2009, Science.

[36]  A. Osterhaus,et al.  Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. , 2009, Vaccine.

[37]  Marion Koopmans,et al.  Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets , 2009, Science.

[38]  J. Yewdell,et al.  Heterosubtypic immunity to influenza A virus: where do we stand? , 2008, Microbes and infection.

[39]  A. Osterhaus,et al.  Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus , 2008, Journal of Virology.

[40]  T. Kuiken,et al.  Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. , 2007, Vaccine.

[41]  S. Epstein.  Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. , 2006, The Journal of infectious diseases.

[42]  G. Kärber,et al.  Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.

[43]  Kim L Kusser,et al.  Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity , 2004, Nature Medicine.

[44]  P. Heinen,et al.  Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. , 2002, The Journal of general virology.

[45]  T. Kuiken,et al.  Pathogenesis of Influenza A (H5N1) Virus Infection in a Primate Model , 2001, Journal of Virology.

[46]  Walter Fiers,et al.  A universal influenza A vaccine based on the extracellular domain of the M2 protein , 1999, Nature Medicine.

[47]  F. Ennis,et al.  Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. , 1999, Journal of immunology.

[48]  A. Osterhaus,et al.  Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine. , 1999, Vaccine.

[49]  A. Osterhaus,et al.  Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. , 1998, Journal of virological methods.

[50]  K. Mozdzanowska,et al.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. , 1994, Journal of immunology.

[51]  R. Ramphal,et al.  Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. , 1980, Infection and immunity.

[52]  P. Small,et al.  Heterotypic immunity to influenza in ferrets , 1980, Infection and immunity.

[53]  G. Alexandrova,et al.  Some problems of modern influenza prophylaxis with live vaccine. , 1977, The Journal of infectious diseases.

[54]  E. D. Kilbourne,et al.  Induction of Partial Specific Heterotypic Immunity in Mice by a Single Infection with Influenza A Virus , 1965, Journal of bacteriology.